Prior Authorization Denied: A Step-by-Step Playbook for Winning Back Coverage of Your Generic Medication

You have been taking the same generic medication for two years. It works. Your doctor prescribed it. Your pharmacy stocks it. Then, without warning, your insurance company declines to cover it—and suddenly a drug that cost you $12 a month is being quoted at $190. The denial letter uses language that sounds clinical and final, but it is neither. Prior authorization denials are, in the majority of cases, reversible. What stands between you and coverage is a process that rewards persistence, documentation, and an understanding of your rights.

This guide is designed to give you exactly that.

Why Insurers Deny Generic Medications

It may seem counterintuitive that an insurance company would deny coverage for a generic drug—the lower-cost alternative that insurers theoretically prefer. In practice, several mechanisms can produce this outcome.

Annual formulary changes. Health plans revise their drug formularies at least once per year, typically effective January 1. A generic that was covered at a preferred tier in the prior plan year may be moved to a non-preferred tier, placed under prior authorization requirements, or removed from the formulary entirely. Patients who are mid-treatment when these changes take effect are particularly vulnerable.

Step therapy requirements. Some insurers require patients to try and fail on one or more lower-cost alternatives before a preferred drug will be approved. If your current generic is not the insurer's preferred product within its therapeutic class, you may be required to demonstrate that alternatives were inadequate—even if you were never on those alternatives to begin with.

Pharmacy benefit manager (PBM) formulary management. Many health plans outsource drug coverage decisions to PBMs, which negotiate rebates with manufacturers and design formularies accordingly. A generic that your prescriber considers clinically appropriate may be disadvantaged on your plan's formulary due to contracting decisions made entirely at the PBM level.

Understanding which of these mechanisms produced your denial is the first step in building an effective appeal.

Obtain the Denial in Writing Immediately

Before taking any other action, request a formal written denial from your insurance company if you have not already received one. Under the Affordable Care Act (ACA) and the Employee Retirement Income Security Act (ERISA), health plans are required to provide written notice of any adverse benefit determination, including:

• The specific reason for the denial
• The plan provision or clinical criteria on which the decision was based
• A description of the appeals process and relevant deadlines
• Information about your right to request a copy of the clinical criteria used

If the denial letter you received does not include all of these elements, contact member services and request a complete adverse benefit determination notice. You will need this document as the foundation of your appeal.

Know Your Deadlines

Appeals processes are time-sensitive, and missing a deadline can forfeit your right to a particular level of review. Under ACA regulations, the following timeframes generally apply to non-grandfathered health plans:

• Urgent care appeals: A decision must be rendered within 72 hours of your request. This is the provision most relevant to patients who need a medication immediately and cannot wait for a standard review.
• Pre-service appeals (non-urgent): The plan must respond within 30 days.
• Post-service appeals: The plan must respond within 60 days.
• External review requests: You typically have four months from the date of a final internal denial to request an independent external review.

Grandfathered plans and self-funded employer plans governed solely by ERISA may operate under somewhat different timelines. Review your Summary Plan Description (SPD) or contact your employer's HR department to confirm the applicable deadlines for your specific plan.

Build Your Internal Appeal: What to Include

The internal appeal is your first formal opportunity to contest the denial, and it is worth investing time in making it substantive. A strong internal appeal typically includes the following components.

A letter of medical necessity from your prescriber. This is the single most important document in your appeal package. Ask your physician to write a letter that specifically addresses the insurer's stated reason for denial, explains why the denied medication is medically necessary for your condition, documents your treatment history and response to the current regimen, and addresses any step therapy requirements by explaining why alternatives are clinically inappropriate for you.

Relevant clinical evidence. If peer-reviewed literature supports the use of your specific medication for your condition, include citations or summaries. Your prescriber or a clinical pharmacist can help identify appropriate references.

Your own treatment history documentation. Pharmacy records showing consistent fills over time, notes from your medical record documenting treatment stability, and any records of prior adverse reactions to alternative medications all strengthen the case that disrupting your current regimen would cause harm.

A direct response to the denial criteria. Request a copy of the clinical criteria your insurer used to deny coverage—you are entitled to this under federal law. Then address each criterion explicitly in your appeal letter. Vague appeals are easier to deny; specific, criteria-responsive appeals require specific counter-arguments.

The 72-Hour Expedited Appeal: When to Use It

If your health or ability to function would be seriously jeopardized by waiting for a standard appeal timeline, you have the right to request an expedited (urgent) review. The 72-hour standard applies when a standard appeal process would seriously jeopardize your life, health, or ability to regain maximum function—or when your physician certifies that a standard timeline would cause severe suffering.

To invoke this right, contact your insurer's member services line, state explicitly that you are requesting an expedited appeal, and ask your prescriber to submit supporting documentation immediately. Follow up the phone call with written confirmation by fax or certified mail, and keep records of every contact.

If the Internal Appeal Fails: External Review

If your internal appeal is denied, you have the right to request an independent external review under the ACA. External review is conducted by an Independent Review Organization (IRO) that has no financial relationship with your insurer. The IRO's decision is binding on the health plan.

External review is particularly powerful in cases involving medical necessity determinations, because the IRO applies clinical standards that are independent of the insurer's formulary preferences. Research consistently shows that patients who pursue external review succeed in reversing denials at meaningful rates.

To initiate external review, submit a written request to your insurer or directly to your state's insurance commissioner, depending on your plan type. Your denial letter must include information on how to access external review; if it does not, contact your state insurance department for guidance.

Additional Leverage Points

File a complaint with your state insurance commissioner. State insurance departments investigate consumer complaints and can apply regulatory pressure that accelerates resolution.

Contact your employer's HR or benefits department. If you are covered through an employer-sponsored plan, HR personnel sometimes have direct relationships with the plan administrator and can escalate issues that member services cannot resolve.

Ask your prescriber about a formulary exception. Many plans have a formal exception process through which a prescriber can request coverage of a non-formulary drug based on medical necessity. This process runs parallel to the appeals process and may resolve the issue more quickly.

Use a bridge supply if available. Some pharmaceutical manufacturers offer patient assistance programs or bridge supplies to cover gaps during the appeals process. Ask your prescriber's office or the manufacturer directly.

A prior authorization denial is not a final answer. It is the beginning of a structured process that, when navigated with documentation and persistence, frequently ends in coverage being restored. The protections available to American patients under federal and state law are meaningful—but only to those who know how to use them.